Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Business Wire

Business Wire

Business Wire is the global leader in news release distribution and regulatory disclosure. Business Wire delivers news and multimedia directly into editorial systems and leading online news platforms and is a trusted source for news organisations, journalists, investment professionals and regulatory authorities.

Results: 8485-8496 of 17993

Business Wire logo

Biocodex Strengthens Supply Chain Resilience with Kinaxis

SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD)

Business Wire logo

ViroCell Biologics Expands U.S. Business Development Team With Two New Appointments

2024 Design Intelligence Award Ceremony Held with Great Splendor (Graphic: Business Wire)

2024 Design Intelligence Award Ceremony Held with Great Splendor

GLAS completes its acquisition of Singaporean corporate, trust and funds service provider, WATIGA (Graphic: Business Wire)

GLAS Completes Its Acquisition of Singaporean Corporate, Trust and Funds Service Provider, WATIGA

Business Wire logo

Celltrion Receives Positive CHMP Opinion for Three Biosimilars in the European Union

Business Wire logo

Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis

Business Wire logo

Experian’s 2024 Global Identity & Fraud Report Spotlights Huge Growth in Highly Personalized GenAI-Driven Fraud Attacks

Onimusha Way of the Sword (Graphic: Business Wire)

Capcom Announces Onimusha Way of the Sword, Marking the First New Title in the Series in Over 20 Years! Work on an Okami Sequel Project Begins!

Business Wire logo

BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell

Business Wire logo

Dealing in Securities by an Executive Officer of AngloGold Ashanti plc

Business Wire logo

CHMP Recommends Approval of Galderma’s Nemolizumab for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis in the European Union

  • Prev Page
  • 1
  • 2
  • …
  • 707
  • 708
  • 709
  • …
  • 1499
  • 1500
  • Next Page

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us